Treating psychiatric disorders during pregnancy requires balancing of risks between minimal maternal–fetal drug exposure and a maximum maternal efficacy. Physiological changes in pregnancy are known to cause changes in drug disposition and may alter antipsychotic concentrations in serum and plasma. However, evidence regarding changes in antipsychotic disposition seen in pregnancy is scarce.
No takes yet. Share an insight, caveat, or question.
Wolfgang Paulus (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: